Dr. Hani Babiker, MD
Claim this profileMayo Clinic in Florida
Studies Tumors
Studies Cancer
11 reported clinical trials
19 drugs studied
Area of expertise
1Tumors
Stage IV
EGFR positive
Stage III
2Cancer
Stage IV
BRAF positive
IDH positive
Affiliated Hospitals
Clinical Trials Hani Babiker, MD is currently running
E6201 + Dabrafenib
for Brain Metastasis from Melanoma
This phase I tests the safety, side effects, and best dose of E6201 in combination with dabrafenib in treating patients with BRAF V600 mutated melanoma that has spread to the central nervous system (central nervous system metastases). E6201 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Dabrafenib is used in patients whose cancer has a mutated (changed) form of a gene called BRAF. It is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals tumor cells to multiply. This helps stop the spread of tumor cells. Giving E6201 and dabrafenib together may work better in treating patients with BRAF V600 mutated melanoma that has spread to the central nervous system than either drug alone.
Recruiting1 award Phase 130 criteria
VG161 + Nivolumab
for Liver Cancer
This trial tests VG161 injections and Nivolumab IV drips in patients with liver cancers. VG161 aims to directly attack cancer cells, while Nivolumab boosts the immune system to help it fight the cancer.
Recruiting1 award Phase 29 criteria
More about Hani Babiker, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Hani Babiker, MD has experience with
- Dabrafenib
- E6201
- Gemcitabine
- BJ-005
- NovoTTF-100L(P)
- NovoTTF-200T
Breakdown of trials Hani Babiker, MD has run
Tumors
Cancer
Pancreatic Cancer
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hani Babiker, MD specialize in?
Hani Babiker, MD focuses on Tumors and Cancer. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are EGFR positive.
Is Hani Babiker, MD currently recruiting for clinical trials?
Yes, Hani Babiker, MD is currently recruiting for 5 clinical trials in Jacksonville Florida. If you're interested in participating, you should apply.
Are there any treatments that Hani Babiker, MD has studied deeply?
Yes, Hani Babiker, MD has studied treatments such as Dabrafenib, E6201, Gemcitabine.
What is the best way to schedule an appointment with Hani Babiker, MD?
Apply for one of the trials that Hani Babiker, MD is conducting.
What is the office address of Hani Babiker, MD?
The office of Hani Babiker, MD is located at: Mayo Clinic in Florida, Jacksonville, Florida 32224-9980 United States. This is the address for their practice at the Mayo Clinic in Florida.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.